Literature DB >> 18076738

Drug interactions in inflammatory bowel disease.

Peter M Irving1, Fergus Shanahan, David S Rampton.   

Abstract

Patients with inflammatory bowel disease (IBD) often require a combination of drugs, some of which are taken for many years, to control their disease. Some of these drugs have potentially serious side effects, which may be initiated or exacerbated by interaction with other agents used to treat IBD. Furthermore, patients with IBD may take treatment for other, unrelated conditions. It is important for doctors who manage patients with IBD to be aware of, and thereby minimize, the dangers presented by such drug interactions. In this review, we summarize the common and important interactions of drugs used in patients with IBD, including some that may be of therapeutic benefit. Particular attention is paid to interactions that occur where both drugs are used to treat IBD.

Entities:  

Mesh:

Year:  2007        PMID: 18076738     DOI: 10.1111/j.1572-0241.2007.01559.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  11 in total

1.  Challenges in the Diagnosis and Management of Inflammatory Bowel Disease in the Elderly.

Authors:  Sasha Taleban
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

Review 2.  Clinical outcomes and management of inflammatory bowel disease in the older patient.

Authors:  Christina Y Ha; Seymour Katz
Journal:  Curr Gastroenterol Rep       Date:  2013-02

3.  Common GI Drug Interactions in the Elderly.

Authors:  Marina Kim; Aamir Dam; Jesse Green
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

4.  Alpha-lipoic acid attenuates trinitrobenzene sulfonic acid-induced ulcerative colitis in mice.

Authors:  Jing Sun; Huijing Zhang; Lin Guan; Huan Zhou; Mingjun Sun
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Anti-colitic effects of kanjangs (fermented soy sauce and sesame sauce) in dextran sulfate sodium-induced colitis in mice.

Authors:  Jia-Le Song; Jung-Ho Choi; Jae-Hoon Seo; Yaung-Iee Lim; Kun-Young Park
Journal:  J Med Food       Date:  2014-09       Impact factor: 2.786

6.  Inflammatory bowel disease of the elderly: a wake-up call.

Authors:  Seymour Katz; Richard Feldstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-05

7.  Modulation of inflammatory response via alpha2-adrenoceptor blockade in acute murine colitis.

Authors:  A Bai; N Lu; Y Guo; J Chen; Z Liu
Journal:  Clin Exp Immunol       Date:  2009-02-04       Impact factor: 4.330

8.  Older age and steroid use are associated with increasing polypharmacy and potential medication interactions among patients with inflammatory bowel disease.

Authors:  Alyssa Parian; Christina Y Ha
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

9.  VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy.

Authors:  Walter E Cromer; Chaitanya V Ganta; Mihir Patel; James Traylor; Christopher G Kevil; J Steven Alexander; J Michael Mathis
Journal:  J Transl Med       Date:  2013-09-11       Impact factor: 5.531

Review 10.  Management of Inflammatory Bowel Disease in the Elderly.

Authors:  Elizabeth S John; Kristina Katz; Mark Saxena; Sita Chokhavatia; Seymour Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.